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Background-—Cardiovascular disease (CVD) is the leading cause of premature disability, yet few prospective studies have
examined functional status (FS) among persons with CVD. Our aim was to examine patterns of change in FS prior to and after
hospitalization for nonfatal myocardial infarction, stroke, and heart failure among members of the Atherosclerosis Risk in
Communities (ARIC) study cohort.
Methods and Results-—FS was assessed using a modified Rosow-Breslau questionnaire administered during routine annual
telephone interviews conducted from 1993 through 2007 among 15 277 ARIC study participants. An FS score was constructed as
a summary measure of responses to questions about participants’ ability to perform selected tasks of daily living (eg, walking half a
mile, climbing stairs). Incidence of CVD was assessed through ARIC surveillance of hospitalized events. Rate of change in FS over
time prior to and following a CVD event was examined using generalized estimating equations. A decline in FS was observed on
average 2 years prior to a myocardial infarction hospitalization and on average 3 years prior to a stroke or heart failure
hospitalization. FS post–myocardial infarction declined relative to pre-event levels but improved to close to pre–myocardial
infarction levels within 3 years. Decline in FS following incident heart failure and stroke remained over time. Observed patterns of
change in FS did not differ appreciably by race or sex.
Conclusions-—This study documents that a decline in FS precedes incidence of CVD-related hospitalization by at least 2 years,
providing a strong argument for routine preventative assessment of FS among older adults. ( J Am Heart Assoc. 2017;6:
e004144. DOI: 10.1161/JAHA.116.004144.)
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W ith the rapidly increasing burden of chronic cardiovas-cular disease (CVD),1,2 primary and secondary preven-
tion efforts require a multilevel approach at the patient and
provider levels across the continuum of care. Assessment of
functional status (FS) is critical to effective prevention and
treatment of chronic disease conditions3,4; however, require-
ments for documentation of FS in routine clinical practice are
only now beginning to be implemented.5 In comparison to
those with functional limitations, patients with high FS report
greater adherence to guideline-recommended medication
regimens,6 possibly as a result of the healthy adherer effect,7
and are more likely to initiate and adhere to recommended
rehabilitation programs.8 In an acknowledgement of the
importance of FS assessment to the evaluation of the
effectiveness of care, the US National Committee for Vital
and Health Statistics has proposed a set of “core health data
elements” to accompany any electronic record of a healthcare
service event, including standardized codes for classifying FS.9
We leveraged annually collected self-reported FS mea-
sures, available for participants of a longitudinal cohort of
middle-aged men and women, the Atherosclerosis Risk in
Communities (ARIC) study, to examine trajectories of FS prior
to and following incident CVD events. Our work was aimed at
underscoring the importance of regular assessment of FS
among individuals at risk for and following a diagnosis of CVD.
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Study Population
The ARIC study cohort was established in 1987 as a
probability sample of 15 792 predominantly black and white
men and women, aged 45 to 64 years, from four communities
in the United States (suburbs of Minneapolis, Minnesota;
Forsyth County, North Carolina; Washington County, Mary-
land; and Jackson, Mississippi).10 The expectation, based on
Framingham Study criteria, was that the majority of the
cohort (95.6%) would be free of coronary heart disease at
baseline. Extensive physical examinations were carried out at
baseline, at three subsequent triennial clinical examinations,
and at the fifth examination conducted in 2011–2013.
Ongoing follow-up of the ARIC cohort is conducted through
annual telephone interviews and surveillance of mortality and
cardiovascular morbidity. We restricted the present analyses
to participants alive as of January 1, 1993 (n=15 377),
excluding participants with self-reported race other than black
or white (n=47) and a nonrepresentative number (n=53) of
black participants from the Minnesota and Maryland study
communities. The final study population was 15 277. Follow-
up for this study was conducted through December 31, 2007.
Event Ascertainment
Hospitalized cardiovascular events were identified through
ongoing active surveillance of medical records in study area
hospitals and through participants’ self-report of prior hospi-
talizations provided during an annual telephone follow-up
interview.10 Incident myocardial infarction (MI) events were
identified based on the presence of International Classification
of Diseases, Ninth Revision (ICD-9) codes 410 and 411.0 in
hospitalization records and adjudicated by a panel of clinical
investigators as definite or probable MI.11 Incident heart failure
(HF) eventswere identified on the basis of the presence of ICD-9
code 428.xx in any position in the medical record.12 Incident
stroke events were identified based on the presence of ICD-9
codes 430 to 438, imaging data from hospitalizations, and the
presence of neurological signs and symptoms, and adjudicated
by a panel of clinical investigators as previously described.13
FS Assessment
An FS questionnaire was administered to ARIC participants
during the annual telephone interviews that were conducted
during the years 1993–2007. Questions included in this
questionnaire were based on the Rosow-Breslau Guttman
scale of functional health for older people.14 An FS score was
constructed by summing responses (yes=1, no=0) across the
following four questions, comprising a modified version of the
Rosow-Breslau questionnaire.
1. Are you able to do your usual activities, such as work
around the house or recreation?
2. Are you able to walk up and down stairs without help?
3. Are you able to do heavy work around the house, such as
shoveling snow or washing windows,
4. Are you able to walk half a mile without help?
Exploratory factor analysis, based on a polychoric matrix that
accounts for categorical component variables, was used to
examine the loading of the individual FS measures on the
composite FS score.15 Of the two factors identified, the first one
explained 97% of the variance, confirming the appropriateness of
the use of the summary FS score comprising all four FSmeasures.
FS was assessed at each year (maximal 8 years) prior to and
following a cardiovascular event among patients who were
disease-free at baseline and receiving an incident diagnosis ofMI
(n=676), patients with an incident HF hospitalization (n=1090),
and patients with an incident stroke hospitalization (n=499). In
the current analysis, we considered incident disease category
groups to bemutually exclusive, such that participants classified
as having had a diagnosis of an MI could not be classified as
having had a HF hospitalization or stroke during the observation
period. Similar exclusions were applied to the classification of
incident HF and incident stroke. Study participants who expe-
rienced multiple different CVD events (eg, MI and HF hospital-
ization) during the observation period formed a separate
category, which we labeled “multiple CVD events” (n=662).
To examine change in FS due to aging, participants who did
not experience stroke, MI, or HF hospitalization during the
years 1993–2007 were considered the CVD-free group, which
consisted of 12 350 participants.
Missing FS data for observations where FS was nonmissing
in the year immediately prior to and following the observation
year were imputed as an average of the two neighboring FS
values. The remaining missing FS data were treated as
missing at random. Death occurring within the observation
period contributed a score of “0” to the individual FS
questionnaire items and to the final FS score.
Health status variables assessed at baseline included body
mass index, classified as normal (<25 kg/m2, referent), over-
weight (25–29 kg/m2), and obese (≥30 kg/m2); diabetes
mellitus, present if fasting serum glucose ≥126 mg/dL, nonfast-
ing serum glucose ≥220 mg/dL, or self-report of taking antidi-
abetic medication or self-reported physician diagnosis within the
previous 2 weeks; hypertension, present if systolic blood
pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg,
or if taking hypertensivemedicationwithin the previous 2 weeks;
drinking and smoking status; and lipid levels including total
cholesterol, high-density lipoprotein cholesterol, low-density
lipoprotein cholesterol, and triglycerides. Educational attainment
was assessed at baseline and categorized as less than high
school graduate or high school and beyond (referent).
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Statistical Analyses
Linear regression models, created separately for each incident
disease category, were used to estimate measures of FS at
annual increments starting with up to 8 years prior to the
cardiovascular event and ending at up to 8 years following the
event. Quadratic growth models, which accounted for
repeated measures of FS, were fitted individually by incident
disease category to identify predictors of change in FS. Time
since the initial FS assessment was modeled using a linear
spline with knots at 3 years pre-event (2 years for MI) and
1 year post-event. Knots were chosen to identify periods of
constant change in FS. Generalized estimating equations were
used to examine change in FS within the selected time
periods prior to a post event. Analyses were adjusted for
baseline age (centered at the mean), and a composite race-
study center variable.
All statistical analyses were conducted using STATA 13
(StataCorp LP, College Station, TX). The ARIC study is in
compliance with the Declaration of Helsinki and has been
approved by institutional review boards of participating
institutions. All study participants provided written consent.
Results
In comparison with participants free of CVD during follow-up,
those who experienced an incident MI, HF, or stroke event
were on average older and more likely to be male, of black
race, to have baseline hypertension and diabetes mellitus, and
to have attained a lower than high school level of education
(Table 1). The baseline proportion of never smokers was
greater among those free of CVD. Baseline lipid levels were
higher among those with subsequent CVD events.
Table 1. Baseline Characteristics of Study Participants Stratified by Follow-Up CVD Events: the ARIC Study Cohort (1993–2007)
Characteristic
Event-Free MI Only HF Only Stroke Only Multiple CVD Events*
n=12 350 n=676 n=1090 n=499 n=662
Age at baseline (SD), y 53.5 (5.6) 54.8 (5.7) 56.4 (5.4) 55.9 (5.6) 56.7 (5.4)
Age at time of event (SD), y N/A 61.8 (6.9) 64.1 (6.7) 63.2 (6.7) 62.7 (6.7)
Male sex, No. (%) 5204 (42) 410 (61) 567 (52) 250 (50) 345 (52)
Black race, No. (%) 3074 (25) 175 (26) 329 (30) 208 (42) 252 (38)
ARIC study center, No. (%)
Forsyth County, NC 3228 (26) 189 (28) 263 (24) 108 (22) 149 (23)
Jackson, MS 2711 (22) 156 (23) 286 (26) 190 (38) 231 (35)
Minneapolis, MN 3323 (27) 175 (26) 190 (17) 99 (20) 109 (16)
Washington County, MD 3088 (25) 156 (23) 351 (32) 102 (20) 173 (26)
BMI, kg/m2 (SD) 27.4 (5.2) 28.2 (5.4) 29.61 (6.3) 28.5 (5.3) 29.5 (5.9)
HDL cholesterol, mmol/L (SD) 1.36 (0.45) 1.18 (0.37) 1.23 (0.41) 1.29 (0.42) 1.21 (0.4)
LDL cholesterol, mmol/L (SD) 3.53 (1) 3.89 (1.06) 3.64 (0.99) 3.67 (1.02) 3.82 (1.07)
Total cholesterol, mmol/L (SD) 5.53 (1.07) 5.83 (1.14) 5.61 (1.08) 5.64 (1.13) 5.82 (1.21)
Triglycerides, mmol/L (SD) 1.44 (0.97) 1.74 (1.11) 1.69 (1.15) 1.57 (0.98) 1.79 (1.44)
Prevalent HF, No. (%) 565 (5) 52 (8) 0 (0) 56 (12) 8 (1)
Prevalent CHD, No. (%) 473 (4) 0 (0) 162 (15) 32 (7) 27 (4)
Hypertension, No. (%) 3756 (31) 294 (44) 534 (49) 282 (57) 378 (57)
Never drinker, No. (%) 3066 (25) 155 (23) 265 (24) 138 (28) 212 (32)
Diabetes mellitus, No. (%) 1061 (9) 125 (19) 237 (22) 93 (19) 228 (35)
<HS education, No. (%) 2550 (21) 182 (27) 397 (36) 165 (33) 271 (41)
Never smoker, No. (%) 5467 (44) 214 (32) 302 (28) 197 (39) 236 (36)
Median time to event (25th percentile,
75th percentile), y
N/A 12.6 (9.3, 15.9) 14.2 (10.2, 17.0) 12.8 (9.3, 16.2) 13.3 (9.7, 16.6)
ARIC indicates Atherosclerosis Risk in Communities; BMI, body mass index; CHD, coronary heart disease; HDL, high-density lipoprotein; HS, high school; LDL, low-density lipoprotein; N/A,
not available.
*Multiple cardiovascular disease (CVD) events: heart failure (HF) and myocardial infarction (MI) (n=380; 57.4%); HF and stroke (n=157; 23.7%); MI and stroke (n=53; 8%); and MI, HF, and
stroke (n=72; 10.9%).
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FS Measures
Compared with participants with no CVD hospitalizations,
those who experienced an incident MI, HF, or stroke were on
average less able to do usual activities such as walk up a flight
of stairs, perform heavy household work, or walk half a mile
during an average 8 years prior to the event (Table 2).
Pre-event
Overall, the greatest limitation observed in the period leading
to the incident CVD hospitalization was seen in participants’
ability to perform heavy household work. Participants who
experienced an incident CVD event were 18% less likely to
report being able to perform this activity prior to the event,
relative to those having no event (relative risk, 0.82; 95% CI,
0.81–0.84). In analyses adjusted for age, sex, race, and ARIC
study center, 76% of participants who had an MI or stroke and
68% of those who had an incident HF hospitalization were able
to perform heavy household work prior to the event.
Post-event
Following the event, 73% of participants who had an MI, 62%
of those who had an incident HF, and 60% who had a stroke
were able to perform heavy household work. Differences in
post- and pre-event FS appeared to be the smallest for MI
(73% pre-event versus 76% post-event; relative risk, 0.96; 95%
CI, 0.93–0.99), compared with stroke and HF.
Table 2. Frequency and Proportion of Decline in Functional Status Pre- and Post-Incident (as Well as Comparison With Those Who
Did Not Have an Event) CVD–Related Hospitalization
Functional Ability
Event Status
MI Only HF Only Stroke Only Multiple CVD Events Event-Free RR: Any Event vs Event-Free
Proportion able to perform activity
Able to do heavy household work
Pre, % 76 68 76 69 85 0.82 (0.81, 0.84)
Post, % 73 62 60 55 0.70 (0.68, 0.72)
Post vs pre (95% CI) 0.96 0.91 0.79 0.80
(0.93–0.99) (0.88–0.96) (0.75–0.85) (0.76–0.85)
Able to do usual activities
Pre, % 88 85 89 87 92 0.94 (0.93, 0.95)
Post, % 79 59 63 58 0.65 (0.63, 0.67)
Post vs pre (95% CI) 0.90 0.70 0.70 0.67
(0.88–0.92) (0.67–0.73) (0.66–0.75) (0.64–0.70)
Able to walk stairs
Pre, % 86 84 88 88 91 0.94 (0.93, 0.96)
Post, % 79 60 62 60 0.66 (0.64, 0.68)
Post vs pre (95% CI) 0.91 0.72 0.70 0.70
(0.89–0.94) (0.69–0.75) (0.65–0.74) (0.65–0.71)
Able to walk half mile
Pre, % 77 72 79 76 86 0.87 (0.85, 0.88)
Post, % 70 43 51 44 0.52 (0.50, 0.55)
Post vs pre (95% CI) 0.90 0.60 0.64 0.58
(0.87–0.94) (0.57–0.64) (0.59–0.69) (0.54–0.62)
Modified Rosow-Breslau Functional Status Score*
Pre 3.27 3.08 3.32 3.21 3.52 0.90 (0.89, 0.91)
Post 2.97 2.20 2.31 2.15 0.62 (0.61, 0.64)
Post vs pre (95% CI) 0.91 0.71 0.69 0.67
(0.89–0.93) (0.69–0.74) (0.66–0.73) (0.64–0.70)
The Atherosclerosis Risk in Communities (ARIC) study cohort 1993–2007. All values are adjusted for age, sex, and race–ARIC study center. CVD indicates cardiovascular disease; HF, heart
failure; MI, myocardial infarction; RR, relative risk.
*Score range: 0 to 4.
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The greatest limitation observed following an incident CVD
hospitalization was participants’ ability to walk half a mile. For
example, 43% of those who had experienced an incident HF
hospitalization were able to walk half a mile. Proportionally,
this constituted 0.60 (95% CI, 0.57–0.64) of those able to
walk that distance prior to the HF hospitalization. For all four
FS measures, the proportion of participants able to perform
the selected activities post-event was consistently lower
among those with incident CVD events, as compared with
those free of CVD.
Changes in FS score status pre- and post-CVD–related
hospitalization
The average FS score observed during up to 8 years prior to a
CVD-related hospitalization was similar among participants
who experienced different incident CVD events. The score
ranged from 3.08 among study participants with incident HF
hospitalization to 3.32 among study participants with incident
stroke. On average during this pre-event time, the FS score
among participants with CVD-related hospitalizations was
0.90 (95% CI, 0.89–0.91) that of the age, race, and sex
comparable group with no CVD event. The mean FS score
averaged over up to 8 years following the clinical event
showed greater variability, from 2.20 observed for study
participants who experienced an incident HF hospitalization to
2.97 for study participants who were hospitalized with
incident MI. The lowest post-event score (2.15) was observed
among study participants who experienced more than one
cardiovascular event. The 5-year average FS score of partic-
ipants who experienced any cardiovascular event was 0.62
(95% CI, 0.61–0.64) that of the age, race, and sex comparable
group with no CVD event.
Exclusion of participants with any form of CVD at baseline
did not alter the results.
Trajectories of FS Pre- and Post-CVD–Related
Hospitalization
In the Figure, we present longitudinal patterns of change in
the FS summary score during the interval of up to 5 years
prior to and up to 5 years following the date of the incident
cardiovascular event. To examine changes potentially due to
aging, the FS summary score was also estimated for study
participants with no CVD hospitalization during the period of
observation (dashed line). All three clinical events, MI, HF, and
stroke, were associated with a subsequent significant
decrease in participants’ FS, with the smallest decrease
observed for participants with incident MI. Study participants
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Figure. Functional status score trajectories pre- and post-event, by event type, compared with functional
status score trajectories among participants with no cardiovascular events in the Atherosclerosis Risk in
Communities (ARIC) study cohort. CVD indicates cardiovascular disease; HF, heart failure; MI, myocardial
infarction.
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who experienced an incident MI event regained their prehos-
pitalization FS within 2 years following the event, with the
mean FS score for this group approaching that of the control
group. Post-discharge FS of study participants experiencing
an incident stroke or HF hospitalization remained below the
level observed prior to the event and below that of the event-
free group.
A similar assessment of longitudinal changes in the
proportion of study participants who were able to perform
usual activities, climb a flight of stairs, perform heavy
household work, and walk half a mile across the years prior
to and following the cardiovascular event confirmed observed
patterns of change in the composite FS score (data not shown).
Rate of change in FS
We defined the event window as the time of 3 years (2 for MI)
pre-event and 1 year post-event, during which we observed a
constant and most pronounced change in FS. We then
examined the change in study participants’ FS score relative
to the FS of the comparison event-free group during that time
and the time prior to and following that period (Table 3). The
greatest recovery in FS occurred within 1 to 4 years following
the hospitalization. For example, in Table 2 we show that the
baseline pre-event FS among participants who experienced
incident HF was 0.90 (95% CI, 0.87–0.92) that of the event-
free group. During the 3 to 8 years prior to the HF
hospitalization, the rate of change in FS of those participants
was not different from the rate of change in FS of the event-
free group. In Table 3, we show that during the event window
(3 years prior to and 1 year post-event), the FS score of study
participants who experienced an HF hospitalization declined
by 0.30 (95% CI, 0.33 to 0.27) units of the summary FS
score per year. A similar magnitude in the decline of the FS
score was observed for study participants who experienced an
incident stroke event (0.33 [95% CI, 0.37 to 0.29] units
per year) or multiple CVD events (0.31 [95% CI, 0.44 to
0.35] units per year). The decline in the summary FS score
during the event window among study participants who
experienced an incident MI was less pronounced at 0.23
(95% CI, 0.27 to 0.19) units per year. During years 2 to 4
following the incident event, FS of all study participants who
experienced a CV event improved, with the greatest improve-
ments observed for those who experienced an incident MI
(0.20 [95% CI, 0.16–0.25] unit increase in the FS score per
year). No substantial changes in FS post year 4 were observed
among study participants who experienced incident HF or
stroke. A slight decrease in FS was observed at that time
among those who experienced an incident MI event or
multiple CVD events.
Analyses repeated among participants without any form of
CVD at baseline yielded the same estimates of rate of change in
FS pre- and post-event. Sensitivity analyses did not reveal sex
or race differences in longitudinal patterns of change in FS prior
to and following cardiovascular events (Figure S1A and S1B).
However, the average FS among women was consistently lower
than the FS of men across all incident CVD conditions and in all
time periods pre- and post-events. The FS of whites was greater
than the FS of blacks prior to and following incidence of MI, HF,
or stroke. Trajectories of FS for all disease conditions were
parallel across sex and race groups, suggesting that the rate of
change in FS was not sex- or race-dependent.
Discussion
In this analysis of longitudinal data from a large biracial cohort
of men and women, we observed an overall decline in FS
during a period of up to 8 years preceding an MI, HF, or
stroke hospitalization. This decline was significantly more
Table 3. Adjusted Estimate of Change* in Functional Status Score Over Time (Years) Before and After a CVD Event Relative to
Those With No Events
Prior to Event Event Window Recovery Period Post-Recovery
(8 to 3 Years) (3 to 1 Year) (+1 to +4 Years) (+4 to +8 Years)
HF only 0 (0.02, 0.02) 0.30 (0.33, 0.27) 0.08 (0.04, 0.12) 0.04 (0.10, 0.01)
Stroke only 0.02 (0.01, 0.05) 0.33 (0.37, 0.29) 0.08 (0.02, 0.14) 0.01 (0.07, 0.06)
Prior to Event Event Window Recovery Period Post-Recovery
(8 to 2 Years) (2 to +1 Year) (+1 to +4 Years) (+4 to +8 Years)
MI only 0.01 (0.31, 0.01) 0.23 (0.27, 0.19) 0.20 (0.16, 0.25) 0.06 (0.11, 0.02)
Multiple CVD
events
0.03 (0.05, 0.01) 0.31 (0.44, 0.35) 0.05 (0.01, 0.09) 0.08 (0.14, 0.28)
The Atherosclerosis Risk in Communities (ARIC) study cohort 1993–2007. All values are adjusted for age, sex, and race–ARIC study center. HF indicates heart failure; MI, myocardial
infarction.
*Change in functional status score among those with any events was estimated relative to change in the functional status score among those free of incident cardiovascular disease (CVD)
events during the same period of observation.
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pronounced following the incident CVD event. Despite modest
improvement in the 2 to 4 years following a stroke or HF
hospitalization, the FS decline was sustained in subsequent
years. By contrast, the FS decline observed following an
incident MI event was followed by an increase in FS to levels
similar to those observed in the year prior to the MI-related
hospitalization. We did not observe race or sex differences in
patterns of FS change prior to and following an incident
cardiovascular hospitalization.
FS assessment is one of the core measures recommended
by the Institute of Medicine,16,17 especially for patients with
complex chronic conditions, who currently constitute 26% of
the US adult population.18,19 Longitudinal assessment of FS
allows for the evaluation of patients’ quality of life and the
effectiveness of care from the patients’ perspective. However,
standardized FS measures are not often used in clinical
practice.20,21 New models of care are gradually transforming
practice patterns from those focused on episodic models of
care towards comprehensive and coordinated care for
complex chronic disease conditions.22 It is within this chronic
care framework that patients’ FS can effectively be optimized
to allow for maintenance of functional capacity, prevention of
decline in function, and preservation of good quality of life.
Chronic conditions, defined by the World Health Organization
as conditions that “require ongoing management over a
period of years or decades,” can impair the person’s ability to
self-manage and impact the caregiver’s capacity to assist with
care. Organizations, such as the American Heart Association,
strongly advocate for the use of patient-reported FS in clinical
care.23 However, routine assessment of FS in clinical settings
is subject to availability of validated, nonproprietary instru-
ments, which can be easily incorporated into electronic health
record platforms.5 A first step in that direction is a set of
recommendations for the development of FS quality metrics
proposed by the Assistant Secretary for Planning and
Evaluation and the Centers for Medicare & Medicaid Ser-
vices.24 Findings from the present study contribute to the
evidence in support of such efforts and underscore the
importance of longitudinal clinical assessment of FS among
older adults with multiple chronic conditions.
In a study based on Health and Retirement Study data, Lee
and colleagues25 observed that a model that included FS
measures in addition to information on comorbidity status
performed better than a comorbidity-only model in the
assessment of the risk of mortality in older adults, thus
underscoring the importance of FS in risk prediction models.
Similar observations of the risk of readmission among
medically complex patients in inpatient rehabilitation facili-
ties26 suggest that FS, which may act as a marker of disease
severity or depression,4 or represent an individual’s suscep-
tibility to disease complications, is critical in the assessment
of post-hospitalization outcomes.
Our finding that the functional limitation most affected by a
CVD-related hospitalization was the ability to walk half a mile
confirms prior observations by Alexander et al,27 in which the
authors conclude that among older adults, walking ability
reflects the ability to perform other activities of daily living.
Inability to walk limits an individual’s ability to engage in the
most common forms of routine physical activity and may
consequently impart increased risk of CVD28 and greater
functional decline.29
The Rosow-Breslau questionnaire, which was used in the
assessment of FS in this study, was developed for commu-
nity-dwelling elderly adults. In that way, it is very applicable
to the population of the present study. The test-retest
reliability of this questionnaire, assessed using the Pearson
correlation coefficient, was found to be high and its
concurrent validity was established through comparison with
other measures of physical performance.30 The Rosow-
Breslau questionnaire items pertain to everyday tasks (such
as performing activities of daily living, including shoveling
snow), which may, however, change in importance with age.
Performance of this questionnaire may therefore be different
in different age groups.
Several additional limitations of this study should be taken
into consideration. Our assessment of FS relied on self-
reported measures only. Furthermore, the time of the FS
assessment, relative to the time of hospitalization for CVD
events, was not the same for all study participants. For some
participants, the time from the hospitalization to the time of
FS assessment could have been sufficient for a certain degree
of FS recovery.
Conclusions
This longitudinal assessment describes patterns of change in
FS among older adults experiencing incident CVD-related
hospitalizations. Our results suggest that changes in FS are
evident at least 2 years prior to the incident CVD hospital-
ization, strongly supporting regular FS assessments among
older adults. Such assessments may prevent or delay
hospitalizations due to CVDs. Studies are needed to deter-
mine predictive utility of change in FS on incident CVD events
and effectiveness of screening and longer-term rehabilitation
interventions. The sustained differences in the overall FS
observed across sex and race groups may be important to
consider with respect to rehabilitation occurring post-
discharge, such that greater emphasis is placed on the use
of rehabilitation services by women and blacks.
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SUPPLEMENTAL MATERIAL 
  
Figure S1A. Functional status score pre and post CVD event, by sex.  
 
Abbreviations: 
CVD: Cardiovascular Disease 
HF: Heart Failure 
MI: Myocardial Infarction 
 
 
 
 
  
Figure S2B. Functional status score pre and post CVD event, by race. 
Abbreviations: 
CVD: Cardiovascular Disease 
HF: Heart Failure 
MI: Myocardial Infarction 
 
 
